<VariationArchive VariationID="496288" VariationName="NM_005359.6(SMAD4):c.1271dup (p.Asp424fs)" VariationType="Duplication" Accession="VCV000496288" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2018-03-17" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="487988" VariationID="496288">
      <GeneList>
        <Gene Symbol="SMAD4" FullName="SMAD family member 4" GeneID="4089" HGNC_ID="HGNC:6770" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51030213" stop="51085042" display_start="51030213" display_stop="51085042" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48556582" stop="48611411" display_start="48556582" display_stop="48611411" Strand="+" />
          </Location>
          <OMIM>600993</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_005359.6(SMAD4):c.1271dup (p.Asp424fs)</Name>
      <CanonicalSPDI>NC_000018.10:51067149:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>18q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51067149" stop="51067150" display_start="51067149" display_stop="51067150" variantLength="1" positionVCF="51067149" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48593519" stop="48593520" display_start="48593519" display_stop="48593520" variantLength="1" positionVCF="48593519" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>D424fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_318" sequenceAccession="LRG_318">
            <Expression>LRG_318:g.104111dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_318t1" sequenceAccession="LRG_318t1">
            <Expression>LRG_318t1:c.1271dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.51067150dup" Assembly="GRCh38">
            <Expression>NC_000018.10:g.51067150dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.48593520dup" Assembly="GRCh37">
            <Expression>NC_000018.9:g.48593520dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013013.2" sequenceAccession="NG_013013" sequenceVersion="2" change="g.104111dup">
            <Expression>NG_013013.2:g.104111dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.6" sequenceAccession="NM_005359" sequenceVersion="6" change="c.1271dup" MANESelect="true">
            <Expression>NM_005359.6:c.1271dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005350.1" sequenceAccession="NP_005350" sequenceVersion="1" change="p.Asp424fs">
            <Expression>NP_005350.1:p.Asp424fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.5" sequenceAccession="NM_005359" sequenceVersion="5" change="c.1271dupA">
            <Expression>NM_005359.5:c.1271dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658684194" DB="ClinGen" />
        <XRef Type="rs" ID="1555686616" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1271dup (p.Asp424fs) AND Generalized juvenile polyposis/juvenile polyposis coli" Accession="RCV000588508" Version="3">
        <ClassifiedConditionList TraitSetID="2255">
          <ClassifiedCondition DB="MedGen" ID="C1868081">Generalized juvenile polyposis/juvenile polyposis coli</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-03-13" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005359.6(SMAD4):c.1271dup (p.Asp424fs) AND Juvenile polyposis syndrome" Accession="RCV001376571" Version="4">
        <ClassifiedConditionList TraitSetID="65684">
          <ClassifiedCondition DB="MedGen" ID="C0345893">Juvenile polyposis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-13" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-03-17" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16152648</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16436638</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22810475</ID>
        </Citation>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="65684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55407" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis+syndrome/3939" DB="Genetic Alliance" />
                <XRef ID="MONDO:0017380" DB="MONDO" />
                <XRef ID="9273005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis juvenile intestinal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis familial of entire gastrointestinal tract</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PJI</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JIP</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">JPS</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3065" />
                <XRef ID="3065" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C0345893" DB="MedGen" />
              <XRef ID="MONDO:0017380" DB="MONDO" />
              <XRef Type="MIM" ID="174900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2255" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2501" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Juvenile polyposis coli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Generalized juvenile polyposis/juvenile polyposis coli</ElementValue>
                <XRef ID="MONDO:0008276" DB="MONDO" />
                <XRef ID="329971" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17508" />
                <XRef ID="17508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <XRef ID="329971" DB="Orphanet" />
              <XRef ID="C1868081" DB="MedGen" />
              <XRef ID="MONDO:0008276" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1364919" SubmissionDate="2018-01-25" DateLastUpdated="2018-03-17" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="NM_005359.5:c.1271dupA|MedGen:C0345893" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000698567" DateUpdated="2018-03-17" DateCreated="2018-03-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: The SMAD4 c.1271dupA (p.Asp424Glufs) variant results in a premature termination codon, predicted to cause a truncated or absent SMAD4 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been reported in association with JPS in HGMD. One in silico tool predicts a damaging outcome for this variant. This variant is absent in 120900 control chromosomes. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005359.5:c.1271dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0345893" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2745465" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="7563028|MedGen:C0345893" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001410416" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16152648</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16436638</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22810475</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 496288). This variant has not been reported in the literature in individuals affected with SMAD4-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asp424Glufs*5) in the SMAD4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMAD4 are known to be pathogenic (PMID: 16152648, 16436638, 22810475).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.48593519_48593520insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0345893" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2745465" TraitType="Disease" MappingType="XRef" MappingValue="C0345893" MappingRef="MedGen">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1364919" TraitType="Disease" MappingType="XRef" MappingValue="C0345893" MappingRef="MedGen">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

